BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29939311)

  • 1. Estimation of the medical need for carbon-ion radiotherapy in Korea.
    Cho I; Seo YS; Jung W; Kim MS
    J Radiat Res; 2018 Sep; 59(5):588-592. PubMed ID: 29939311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical experience of carbon ion radiotherapy for malignant tumors].
    Ishikawa H; Tsuji H; Tsujii H
    Gan To Kagaku Ryoho; 2006 Apr; 33(4):444-9. PubMed ID: 16612151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon ion radiotherapy: clinical experiences at National Institute of Radiological Science (NIRS).
    Okada T; Kamada T; Tsuji H; Mizoe JE; Baba M; Kato S; Yamada S; Sugahara S; Yasuda S; Yamamoto N; Imai R; Hasegawa A; Imada H; Kiyohara H; Jingu K; Shinoto M; Tsujii H
    J Radiat Res; 2010; 51(4):355-64. PubMed ID: 20508375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of clinical experiences on carbon ion radiotherapy at NIRS.
    Tsujii H; Mizoe JE; Kamada T; Baba M; Kato S; Kato H; Tsuji H; Yamada S; Yasuda S; Ohno T; Yanagi T; Hasegawa A; Sugawara T; Ezawa H; Kandatsu S; Yoshikawa K; Kishimoto R; Miyamoto T
    Radiother Oncol; 2004 Dec; 73 Suppl 2():S41-9. PubMed ID: 15971308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Present status of carbon ion radiotherapy for malignant tumors].
    Sugahara S; Kamada T
    Gan To Kagaku Ryoho; 2009 Nov; 36(11):1795-800. PubMed ID: 19920380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-institutional Study of Carbon-ion Radiotherapy for Locally Advanced Pancreatic Cancer: Japan Carbon-ion Radiation Oncology Study Group (J-CROS) Study 1403 Pancreas.
    Kawashiro S; Yamada S; Okamoto M; Ohno T; Nakano T; Shinoto M; Shioyama Y; Nemoto K; Isozaki Y; Tsuji H; Kamada T
    Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1212-1221. PubMed ID: 29907490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the accuracy and clinical practicality of a calculation system for patient positional displacement in carbon ion radiotherapy at five sites.
    Kubota Y; Hayashi H; Abe S; Souda S; Okada R; Ishii T; Tashiro M; Torikoshi M; Kanai T; Ohno T; Nakano T
    J Appl Clin Med Phys; 2018 Mar; 19(2):144-153. PubMed ID: 29369463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evidence of particle beam therapy (carbon).
    Kamada T
    Int J Clin Oncol; 2012 Apr; 17(2):85-8. PubMed ID: 22426888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the use of protons and carbon ions for treatment.
    Uhl M; Herfarth K; Debus J
    Cancer J; 2014; 20(6):433-9. PubMed ID: 25415691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment with carbon-ion radiotherapy and its combinations -- basic biological studies and investigations at the National Institute of Radiological Sciences].
    Imai T
    Gan To Kagaku Ryoho; 2015 Feb; 42(2):154-8. PubMed ID: 25743134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Particle beam radiotherapy].
    Saitoh J; Nakano T
    Gan To Kagaku Ryoho; 2014 Dec; 41(13):2546-9. PubMed ID: 25596047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the need and utilization of radiotherapy in cancers of the breast, cervix, lung, prostate and rectum: A population level study.
    Shack L; Lu S; Weeks LA; Craighead P; Kerba M
    Radiother Oncol; 2017 Jan; 122(1):152-158. PubMed ID: 28012795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Study of Carbon-Ion Radiation Therapy for Adenoid Cystic Carcinoma of the Head and Neck: Subanalysis of the Japan Carbon-Ion Radiation Oncology Study Group (J-CROS) Study (1402 HN).
    Sulaiman NS; Demizu Y; Koto M; Saitoh JI; Suefuji H; Tsuji H; Ohno T; Shioyama Y; Okimoto T; Daimon T; Nemoto K; Nakano T; Kamada T;
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):639-646. PubMed ID: 29413278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbon-ion Radiotherapy for Prostate Cancer: Analysis of Morbidities and Change in Health-related Quality of Life.
    Ishikawa H; Katoh H; Kaminuma T; Kawamura H; Ito K; Matsui H; Hirato J; Shimizu N; Takezawa Y; Tsuji H; Suzuki K; Ohno T; Nakano T;
    Anticancer Res; 2015 Oct; 35(10):5559-66. PubMed ID: 26408726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of late rectal normal tissue complication probability parameters in carbon ion therapy for prostate cancer.
    Fukahori M; Matsufuji N; Himukai T; Kanematsu N; Mizuno H; Fukumura A; Tsuji H; Kamada T
    Radiother Oncol; 2016 Jan; 118(1):136-40. PubMed ID: 26700600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Report on the 43rd Congress of the American Society for Therapeutic Radiology and Oncology (ASTRO), San Francisco, 4-8 November 2001].
    Noël G; Mazeron JJ
    Cancer Radiother; 2002 Feb; 6(1):50-8. PubMed ID: 11899681
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II multi-institutional clinical trial on a new mixed beam RT scheme of IMRT on pelvis combined with a carbon ion boost for high-risk prostate cancer patients.
    Marvaso G; Jereczek-Fossa BA; Vischioni B; Ciardo D; Giandini T; Hasegawa A; Cattani F; Carrara M; Ciocca M; Bedini N; Villa S; Morlino S; Russo S; Zerini D; Colangione SP; Panaino CMV; Fodor C; Santoro L; Pignoli E; Valvo F; Valdagni R; De Cobelli O; Orecchia R
    Tumori; 2017 May; 103(3):314-318. PubMed ID: 28009421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical experiences with intraoperative radiotherapy of locally advanced carcinomas].
    Abe M; Takahashi M
    Strahlentherapie; 1982 Oct; 158(10):585-93. PubMed ID: 7179341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Results of Carbon Ion Radiotherapy at NIRS.
    Tsujii H; Mizoe J; Kamada T; Baba M; Tsuji H; Kato H; Kato S; Yamada S; Yasuda S; Ohno T; Yanagi T; Imai R; Kagei K; Kato H; Hara R; Hasegawa A; Nakajima M; Sugane N; Tamaki N; Takagi R; Kandatsu S; Yoshikawa K; Kishimoto R; Miyamoto T
    J Radiat Res; 2007; 48 Suppl A():A1-A13. PubMed ID: 17513896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carbon ion radiotherapy in advanced hypofractionated regimens for prostate cancer: from 20 to 16 fractions.
    Okada T; Tsuji H; Kamada T; Akakura K; Suzuki H; Shimazaki J; Tsujii H;
    Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):968-72. PubMed ID: 22898380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.